MedTrace Logo

Use of CoG by Patients With Diabetes Mellitus

NCT03840161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-01-18

No results posted yet for this study

Summary

The CNOGA Combo Glucometer (CoG) employs an invasive glucose meter using blood glucose teststrips and requiering a capillary blood sample obtained from a fingerstick and in addition, a non-invasive optical component for prediction of tissue glucose at the fingertip. In this study, participants will use both devices during meal tests and also at home during routine care. The results from the device will be compared to a standard reference method and will be used to determine the accuracy of the two device components.

Conditions

Interventions

DEVICE

non-invasive tissue glucose prediction

Generation of non-invasive and invasive glucose readings for comparison with a standard laboratory reference glucose determination method (YSI glucose analyzer)

Sponsors & Collaborators

  • Cnoga Medical Ltd.

    collaborator INDUSTRY

  • Sciema UG

    lead OTHER

Principal Investigators

  • Filiz Demircik, PhD · Sciema UG

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-16
Primary Completion
2019-02-28
Completion
2019-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03840161 on ClinicalTrials.gov